Fire: Created page with "{{Navbox | name = Lipid modifying agents | title = Lipid-lowering agents (C10) | state = {{{state|autocollapse}}} | listclass = hlist | group1 = GI tract | list1 = {{Navbox|child | group1 = Cholesterol absorption inhibitors, NPC1L1 | list1 = * Ezetimibe * SCH-48461 | group2 = Bile acid sequestrants/resins (Low..."

2024-02-19T15:23:45Z

Created page with "{{Navbox | name = Lipid modifying agents | title = Lipid-lowering agents (C10) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = GI tract | list1 = {{Navbox|child | group1 = Cholesterol absorption inhibitors, NPC1L1 | list1 = * Ezetimibe * SCH-48461 | group2 = Bile acid sequestrants/resins (Low..."

New page

{{Navbox
| name = Lipid modifying agents
| title = [[Hypolipidemic agent|Lipid-lowering agents]] ([[ATC code C10|C10]])
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| listclass = hlist

| group1 = [[Human gastrointestinal tract|GI tract]]
| list1 = {{Navbox|child

| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
| list1 =
* [[Ezetimibe]]
* [[SCH-48461]]

| group2 = [[Bile acid sequestrant]]s/[[Ion-exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
| list2 =
* [[Colesevelam]]
* [[Colestilan]]
* [[Colestipol]]
* [[Colestyramine]]
* [[Colextran]]
* [[Dietary fiber|Soluble fiber]] such as [[psyllium]] and [[glucomannan]]
}}

| group2 = [[Liver]]
| list2 = {{Navbox|child

| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
| list1 =
* [[Atorvastatin]]
* [[Cerivastatin]]‡
* [[Fluvastatin]]
* [[Lovastatin]]
* [[Mevastatin]]
* [[Pitavastatin]]
* [[Pravastatin]]
* [[Rosuvastatin]]
* [[Simvastatin]]#

| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
| list2 =
* [[Acipimox]]
* [[Aluminium nicotinate]]
* [[Niacin]]
* [[Niceritrol]]
* [[Nicofuranose]]
* [[Nicotinyl alcohol]]

| group3 = [[Microsomal triglyceride transfer protein|MTTP]] inhibitors ([[Very low-density lipoprotein|VLDL]])
| list3 =
* [[Dirlotapide]]
* [[Lomitapide]]
* [[Mitratapide]]

| group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]])
| list4 =
* [[Bempedoic acid]]
|group5= [[Thyromimetic]]s (VLDL)
|list5=
* [[Dextrothyroxine]]‡
*[[Resmetirom]]
}}

| group3 = [[Blood vessel]]s
| list3 = {{Navbox|child
| evenodd = swap

| group1 = [[PPAR agonist]]s (LDL)
| list1 =
{{Navbox|child
| group1 = [[Fibrate]]s
| list1 =

* [[Aluminium clofibrate]]
* [[Bezafibrate]]
* [[Choline fenofibrate]]
* [[Ciprofibrate]]
* [[Clinofibrate]]
* [[Clofibrate]]‡
* [[Clofibride]]
* [[Etofibrate]]
* [[Fenofibrate]]
* [[Gemfibrozil]]
* [[Nafenopin]]
* [[Pemafibrate]]
* [[Ronifibrate]]
* [[Simfibrate]]
|group2=Others
|list2=
*[[GW501516]]§
}}
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
| list2 =
* [[Anacetrapib]]†
* [[Dalcetrapib]]§
* [[Evacetrapib]]§
* [[Obicetrapib]]†
* [[Torcetrapib]]§

| group3 = [[PCSK9 inhibitor]]s ([[Low-density lipoprotein|LDL]])
| list3 =
* [[Alirocumab]]
* [[Bococizumab]]
* [[Evolocumab]]
* [[Inclisiran]]

| group4 = [[ANGPTL3]] inhibitors ([[Low-density lipoprotein|LDL]]/[[High-density lipoprotein|HDL]])
| list4 =
* [[Evinacumab]]

}}

| group4 = Combinations
| list4 =
* [[Amlodipine/atorvastatin]]
* [[Bempedoic acid/ezetimibe]]
* [[Ezetimibe/atorvastatin]]
* [[Ezetimibe/rosuvastatin]]
* [[Ezetimibe/simvastatin]]
* [[Fenofibrate/pravastatin]]
* [[Fenofibrate/simvastatin]]
* [[Laropiprant|Niacin/laropiprant]]
* [[Niacin/lovastatin]]
* [[Niacin/simvastatin]]

| group5 = Other
| list5 =
* [[Alipogene tiparvovec]]
* [[Azacosterol]]
* [[Azalanstat]]
* [[Benfluorex]]‡
* [[Darapladib]]§
* [[Lapaquistat]]§
* [[Magnesium pyridoxal 5-phosphate glutamate]]
* [[Meglutol]]
* [[Mipomersen]]
* [[Omega-3-triglycerides]]
* [[Policosanol]]
* [[Probucol]]
* [[Tiadenol]]
* [[Triparanol]]‡
* [[Volanesorsen]]

| list6 = {{PharmNavFootnote}}

}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by ATC]]
</noinclude>

Template:Lipid modifying agents - Revision history